Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does not cancel out hormonal birth control in the way many people fear. The pill's effectiveness is not directly blocked by semaglutide itself — but there is a specific, practical consideration about oral contraceptives and absorption that is worth understanding clearly. These are prescription-only medicines, and a prescriber will discuss contraception as part of any clinical assessment. Here is what the evidence says.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people searching this question have heard that Wegovy or semaglutide somehow 'cancels' the pill, rendering contraception useless. That picture is not accurate. Semaglutide does not block oestrogen or progestogen, and it does not switch off the hormones in your contraceptive. The more precise concern is narrower: because semaglutide slows gastric emptying as part of how it works, there is a theoretical window where an oral tablet taken on the same day is absorbed more slowly or less completely than usual. That is a meaningful practical distinction. For most long-acting contraceptive methods, it simply does not apply, and once you know that, much of the anxiety around this question dissolves.
The NHS guidance on weight-management injections addresses this directly, advising that patients discuss their contraceptive method before starting treatment. That conversation is a routine part of clinical assessment, not a warning that semaglutide is dangerous to combine with contraception.
Semaglutide slows the rate at which the stomach empties its contents into the small intestine. For most oral medicines this effect is modest and clinically irrelevant. For combined or progesterone-only pills, the concern is that absorption of the active hormone could be slightly altered during the period when gastric emptying is most affected, typically in the first few weeks of treatment or after a dose increase, when nausea and GI symptoms tend to be at their highest.
UK guidance therefore suggests that women who rely on the oral contraceptive pill consider adding a non-oral method of contraception during this window. That might mean condoms, or switching to a method that bypasses the gut entirely. Worth noting: there is currently no evidence of widespread contraceptive failure linked to semaglutide use, and the guidance is precautionary. If you want to explore how this applies to your specific situation, our detailed look at how Wegovy affects birth control covers this in further depth.
If you are already taking semaglutide, have questions and are not sure who to turn to, a good first port of call is the healthcare team supervising your treatment, at nume that means our clinical team is available seven days a week.
Long-acting reversible contraceptives (LARCs) bypass the absorption question entirely. The hormonal coil (IUS), copper coil (IUD), contraceptive implant and injectable contraception all release hormones directly into tissue or the bloodstream (or, in the case of the copper coil, work non-hormonally) so gastric emptying has no bearing on how well they work.
The contraceptive patch and vaginal ring also absorb their hormones through the skin or vaginal mucosa rather than the gut, meaning they are similarly unaffected. If you currently use one of these methods and are wondering whether starting Wegovy (semaglutide) will change anything for you, the honest answer is: it is very unlikely to. A prescriber should still be told about all medicines and contraceptives you use as part of any consultation, that is standard clinical practice, not a reason to worry.
People curious about the broader picture of how semaglutide interacts with birth control overall will find the absorption question is the central one, regardless of how the question is phrased.
Semaglutide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. This is separate from the contraception absorption question, it is a licensing restriction based on the absence of safety data in pregnancy, not on any proven harm in humans. Women of childbearing age who are on semaglutide and considering a planned pregnancy are advised to stop treatment and allow a wash-out period before trying to conceive; your prescriber will advise on the appropriate timeframe.
The MHRA's Yellow Card scheme is the right place to report any unexpected effects you experience while on treatment, including anything related to contraception. And if you are weighing up whether a GLP-1 medicine is right for you at this stage of life, checking your eligibility with a prescriber is the most useful next step, our free consultation is a good place to start that conversation.
For a broader look at semaglutide as a treatment (how it works, what it is licensed for and what to expect) our overview covers the full picture, and anyone who has encountered semaglutide offered through med spas, where clinical oversight can vary considerably, should be aware that the same contraception considerations apply regardless of the setting. Questions about cost and what private treatment includes are addressed on our Wegovy pricing page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.